Wednesday, February 10, 2010, 8:48pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Celgene Corporation (CELG)

At 5:00AM SGT: 55.50 USD   0.00 (0.00%)  
 MORE ON CELG 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Celgene Corporation (NasdaqNM:CELG) Delayed quote dataEdit
Last Trade:55.50 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:55.50
Open:N/A
Bid:55.50 x 500
Ask:65.00 x 100
1y Target Est:65.15
Day's Range:N/A - N/A
52wk Range:36.90 - 59.67
Volume:0
Avg Vol (3m):3,835,570
Market Cap:25.51B
P/E (ttm):69.20
EPS (ttm):0.80
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add CELG to Portfolio   Download Data

 HEADLINES 
•You'll Become a Millionaire -- Here's When
at Motley Fool (Tue 12:56am)
•The Stocks With the Most Potential
at Motley Fool (Fri, Feb 5)
•Onyx and FDA agree on cancer drug study design
AP (Tue, Feb 2)
•In Cautionary Mode: Overweight Tech, Healthcare, Consumer Staples, Emerging /Frontier Markets
at Seeking Alpha (Tue, Feb 2)
•'Fast Money' Recap: Rally Worries
at TheStreet.com (Tue, Feb 2)
•Big Week For Pharma
at CNBC (Tue, Feb 2)
•New Star Analyst Rankings for Celgene Corporation
StarMine (Sat, Jan 30)
•Loosen Up, Tightwads!
at Barrons.com (Sat, Jan 30)
•Wake Up! You Still Have to Pay Attention
at Motley Fool (Sat, Jan 30)
•Celgene Beats Zacks Estimate
Zacks.com (Fri, Jan 29)
•1-Star Stocks Poised to Plunge: Cytori Therapeutics?
at Motley Fool (Fri, Jan 29)
•Celgene Corporation Q4 2009 Earnings Call Transcript
at Seeking Alpha (Fri, Jan 29)
More Headlines for CELG...
 ANALYST 
EPS Est (next year) (Dec-09) :2.08
EPS Est (in 2 years) (Dec-10) :2.63
Avg Rec (current)*:2.0
PEG Ratio:1.15
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Celgene Corporation engages in the discovery, development, and commercialization of innovative therapies to treat cancer and immune-inflammatory related diseases primarily in Europe and the United States.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices